Collegium Pharmaceutical (COLL) Inventory (2016 - 2026)

Collegium Pharmaceutical has reported Inventory for 11 years, with the latest figure at $113.3 million in Q2 2026.

• On a quarterly basis, Inventory rose 196.92% year-over-year to $113.3 million in Q2 2026; TTM through Jun 2026 was $113.3 million, a 196.92% increase from a year earlier, with the FY2025 full-year figure at $40.9 million, up 15.05% from the prior year.
• Inventory was $113.3 million for Q2 2026 at Collegium Pharmaceutical, up from $42.7 million in the prior quarter.
• The five-year high for Inventory was $113.3 million in Q2 2026, with the low at $26.0 million in Q2 2023.
• Average Inventory over 5 years is $46.5 million, with a median of $38.0 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2023: Inventory surged 417.14% in 2022, then plunged 66.53% in 2023.
• Over 5 years, Inventory stood at $46.5 million in 2022, then tumbled by 30.47% to $32.3 million in 2023, then rose by 9.98% to $35.6 million in 2024, then rose by 15.05% to $40.9 million in 2025, then soared by 176.86% to $113.3 million in 2026.
• The last three Inventory figures came in at $113.3 million (Q2 2026), $42.7 million (Q1 2026), and $40.9 million (Q4 2025), per Business Quant data.